Show
Sort by
-
- Journal Article
- A1
- open access
Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2) : a potential strategy to improve the efficacy of oncological photodynamic therapy
-
- Journal Article
- A1
- open access
Polo-like kinase 1 (PLK1) is a novel CARD14-binding protein in keratinocytes
-
The 'ABC' of split-nanoluciferase HIF heterodimerization bioassays : applications, Benefits & Considerations
-
- Journal Article
- A1
- open access
Polo-like kinase 1 (PLK1) signaling in cancer and beyond
-
Targeting neutrophils in asthma : a therapeutic opportunity?
-
Withaferin A : from ayurvedic folk medicine to preclinical anti-cancer drug
-
Phytohormones : multifunctional nutraceuticals against metabolic syndrome and comorbid diseases
-
- Journal Article
- A1
- open access
Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HT2AR through simultaneous use of beta-arrestin 2 and miniG alpha(q) bioassays
-
Assessment of biased agonism at the A(3) adenosine receptor using beta-arrestin and miniG alpha(i) recruitment assays
-
- Journal Article
- A1
- open access
Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform